Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid - PubMed

Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid

Eileen F O'Shea et al. Int J Food Microbiol. 2012.

Abstract

The mechanisms by which intestinal bacteria achieve their associated health benefits can be complex and multifaceted. In this respect, the diverse microbial composition of the human gastrointestinal tract (GIT) provides an almost unlimited potential source of bioactive substances (pharmabiotics) which can directly or indirectly affect human health. Bacteriocins and fatty acids are just two examples of pharmabiotic substances which may contribute to probiotic functionality within the mammalian GIT. Bacteriocin production is believed to confer producing strains with a competitive advantage within complex microbial environments as a consequence of their associated antimicrobial activity. This has the potential to enable the establishment and prevalence of producing strains as well as directly inhibiting pathogens within the GIT. Consequently, these antimicrobial peptides and the associated intestinal producing strains may be exploited to beneficially influence microbial populations. Intestinal bacteria are also known to produce a diverse array of health-promoting fatty acids. Indeed, certain strains of intestinal bifidobacteria have been shown to produce conjugated linoleic acid (CLA), a fatty acid which has been associated with a variety of systemic health-promoting effects. Recently, the ability to modulate the fatty acid composition of the liver and adipose tissue of the host upon oral administration of CLA-producing bifidobacteria and lactobacilli was demonstrated in a murine model. Importantly, this implies a potential therapeutic role for probiotics in the treatment of certain metabolic and immunoinflammatory disorders. Such examples serve to highlight the potential contribution of pharmabiotic production to probiotic functionality in relation to human health maintenance.

Similar articles

• Metabolic activities and probiotic potential of bifidobacteria.

  Russell DA, Ross RP, Fitzgerald GF, Stanton C. Russell DA, et al. Int J Food Microbiol. 2011 Sep 1;149(1):88-105. doi: 10.1016/j.ijfoodmicro.2011.06.003. Epub 2011 Jun 24. Int J Food Microbiol. 2011. PMID: 21763022 Review.

• Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice.

  Rosberg-Cody E, Stanton C, O'Mahony L, Wall R, Shanahan F, Quigley EM, Fitzgerald GF, Ross RP. Rosberg-Cody E, et al. Microbiology (Reading). 2011 Feb;157(Pt 2):609-615. doi: 10.1099/mic.0.043406-0. Epub 2010 Dec 22. Microbiology (Reading). 2011. PMID: 21178166

• Lactobacillus salivarius: bacteriocin and probiotic activity.

  Messaoudi S, Manai M, Kergourlay G, Prévost H, Connil N, Chobert JM, Dousset X. Messaoudi S, et al. Food Microbiol. 2013 Dec;36(2):296-304. doi: 10.1016/j.fm.2013.05.010. Epub 2013 Jun 15. Food Microbiol. 2013. PMID: 24010610 Review.

• Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species.

  Coakley M, Ross RP, Nordgren M, Fitzgerald G, Devery R, Stanton C. Coakley M, et al. J Appl Microbiol. 2003;94(1):138-45. doi: 10.1046/j.1365-2672.2003.01814.x. J Appl Microbiol. 2003. PMID: 12492934

• Fatty acid profile, trans-octadecenoic, α-linolenic and conjugated linoleic acid contents differing in certified organic and conventional probiotic fermented milks.

  Florence AC, Béal C, Silva RC, Bogsan CS, Pilleggi AL, Gioielli LA, Oliveira MN. Florence AC, et al. Food Chem. 2012 Dec 15;135(4):2207-14. doi: 10.1016/j.foodchem.2012.07.026. Epub 2012 Jul 15. Food Chem. 2012. PMID: 22980792

Cited by

• Bacteriocins - a viable alternative to antibiotics?

  Cotter PD, Ross RP, Hill C. Cotter PD, et al. Nat Rev Microbiol. 2013 Feb;11(2):95-105. doi: 10.1038/nrmicro2937. Epub 2012 Dec 24. Nat Rev Microbiol. 2013. PMID: 23268227 Review.

• Randomized, Double-Blind Placebo-Controlled Trial to Assess the Effect of Probiotics on Irritable Bowel Syndrome in Veterans With Gulf War Illness.

  Tuteja AK, Talley NJ, Murtaugh MA, Loc-Carrillo CM, Stoddard GJ, Anderson GL. Tuteja AK, et al. Fed Pract. 2022 Oct;39(10):410-417. doi: 10.12788/fp.0322. Epub 2022 Oct 12. Fed Pract. 2022. PMID: 36744017 Free PMC article.

• The Role of Probiotics in Alleviating Postweaning Diarrhea in Piglets From the Perspective of Intestinal Barriers.

  Su W, Gong T, Jiang Z, Lu Z, Wang Y. Su W, et al. Front Cell Infect Microbiol. 2022 May 30;12:883107. doi: 10.3389/fcimb.2022.883107. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35711653 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database